Suppr超能文献

接受血液透析治疗的慢性肾病患者的降钙素分泌情况。

Calcitonin secretion in chronic renal patients treated with hemodialysis.

作者信息

Gozariu L, Manasia M, Paţiu I M, Vlăduţiu D, Barabas E, Spânu C, Căprioară M

出版信息

Endocrinologie. 1981 Oct-Dec;19(4):253-6.

PMID:7323650
Abstract

Calcitonin levels were studied in 18 patients with chronic renal insufficiency periodically hemodialysed, comparatively with 9 only drug-treated uremic patients. Calcitonin was radioimmunologically assayed before and after hemodialysis and repeated 5 months later in some of the patients. Serum calcitonin was increased in most of the studied patients, especially in the dialysed ones and with a creatinine clearance below 10 ml/min. Calcitonin concentration was all the more increased as the dialytic treatment lasted longer. Considering the increasing role of calcitonin as osteoprotector, these findings might be of interest in the treatment of renal osteopathy.

摘要

对18例定期进行血液透析的慢性肾功能不全患者的降钙素水平进行了研究,并与9例仅接受药物治疗的尿毒症患者进行了比较。在血液透析前后采用放射免疫法测定降钙素水平,部分患者在5个月后重复测定。大多数研究患者的血清降钙素水平升高,尤其是接受透析治疗且肌酐清除率低于10 ml/min的患者。透析治疗持续时间越长,降钙素浓度升高越明显。鉴于降钙素作为骨保护剂的作用日益增强,这些发现可能对肾性骨病的治疗具有重要意义。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验